Literature DB >> 21534527

Inhibition of Myosin ATPase activity by halogenated pseudilins: a structure-activity study.

Matthias Preller1, Krishna Chinthalapudi, Renee Martin, Hans-Joachim Knolker, Dietmar J Manstein.   

Abstract

Myosin activity is crucial for many biological functions. Strong links have been established between changes in the activity of specific myosin isoforms and diseases such as cancer, cardiovascular failure, and disorders of sensory organs and the central nervous system. The modulation of specific myosin isoforms therefore holds a strong therapeutic potential. In recent work, we identified members of the marine alkaloid family of pseudilins as potent inhibitors of myosin-dependent processes. Here, we report the crystal structure of the complex between the Dictyostelium myosin 2 motor domain and 2,4-dichloro-6-(3,4,5-tribromo-1H-pyrrole-2-yl)phenol (3). Detailed comparison with previously solved structures of the myosin 2 complex with bound pentabromopseudilin (2a) or pentachloropseudilin (4a) provides insights into the molecular basis of the allosteric communication between the catalytic and the allosteric sites. Moreover, we describe the inhibitory potency for a congeneric series of halogenated pseudilins. Insight into their mode of action is gained by applying a combination of experimental and computational approaches.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21534527     DOI: 10.1021/jm200259f

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  16 in total

1.  Azidoblebbistatin, a photoreactive myosin inhibitor.

Authors:  Miklós Képiró; Boglárka H Várkuti; Andrea Bodor; György Hegyi; László Drahos; Mihály Kovács; András Málnási-Csizmadia
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-30       Impact factor: 11.205

2.  Phenamacril is a reversible and noncompetitive inhibitor of Fusarium class I myosin.

Authors:  Rasmus D Wollenberg; Manuel H Taft; Sven Giese; Claudia Thiel; Zoltán Balázs; Henriette Giese; Dietmar J Manstein; Teis E Sondergaard
Journal:  J Biol Chem       Date:  2018-11-30       Impact factor: 5.157

3.  Structural and mechanistic insights into the function of the unconventional class XIV myosin MyoA from Toxoplasma gondii.

Authors:  Cameron J Powell; Raghavendran Ramaswamy; Anne Kelsen; David J Hamelin; David M Warshaw; Jürgen Bosch; John E Burke; Gary E Ward; Martin J Boulanger
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-22       Impact factor: 11.205

4.  Mechanism and specificity of pentachloropseudilin-mediated inhibition of myosin motor activity.

Authors:  Krishna Chinthalapudi; Manuel H Taft; René Martin; Sarah M Heissler; Matthias Preller; Falk K Hartmann; Hemma Brandstaetter; John Kendrick-Jones; Georgios Tsiavaliaris; Herwig O Gutzeit; Roman Fedorov; Folma Buss; Hans-Joachim Knölker; Lynne M Coluccio; Dietmar J Manstein
Journal:  J Biol Chem       Date:  2011-06-16       Impact factor: 5.157

5.  Mechanism of action-based classification of antibiotics using high-content bacterial image analysis.

Authors:  Kelly C Peach; Walter M Bray; Dustin Winslow; Peter F Linington; Roger G Linington
Journal:  Mol Biosyst       Date:  2013-04-23

Review 6.  Poorly understood aspects of striated muscle contraction.

Authors:  Alf Månsson; Dilson Rassier; Georgios Tsiavaliaris
Journal:  Biomed Res Int       Date:  2015-04-16       Impact factor: 3.411

Review 7.  Small-molecule inhibitors of myosin proteins.

Authors:  Lisa M Bond; David A Tumbarello; John Kendrick-Jones; Folma Buss
Journal:  Future Med Chem       Date:  2013-01       Impact factor: 3.808

Review 8.  Nonmuscle myosin-2: mix and match.

Authors:  Sarah M Heissler; Dietmar J Manstein
Journal:  Cell Mol Life Sci       Date:  2012-05-08       Impact factor: 9.261

9.  Kinetic properties and small-molecule inhibition of human myosin-6.

Authors:  Sarah M Heissler; Jayashankar Selvadurai; Lisa M Bond; Roman Fedorov; John Kendrick-Jones; Folma Buss; Dietmar J Manstein
Journal:  FEBS Lett       Date:  2012-07-31       Impact factor: 4.124

10.  Structural basis for drug-induced allosteric changes to human β-cardiac myosin motor activity.

Authors:  Donald A Winkelmann; Eva Forgacs; Matthew T Miller; Ann M Stock
Journal:  Nat Commun       Date:  2015-08-06       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.